NEU - Neuren Pharmaceuticals

[trillionaire#1]

well i took up a small holding today after i was stopped out of (bly)boart longyear.

i feel like ive turned up late for the party though,would have been a nice pick
up at 1cent or less!!!

 

[johannlo]

On another run today but only started after lunch!!! up from 3.6 to 4.2 right now, no announcements or anything official to account for this.

No 'major' trades either the biggest trade today is 283,659 XT @ 4.5 which is ~12k dollars.

Anybody with insight?

 

[johannlo]

ANNOUNCEMENT - 14 million in funding from Uncle Sam's army

Phew that was looking like a close run thing as it dipped into the high 1s....

 

[gaps]

Neuren obtains further US$14 million funding from US Army

• Most costs for the upcoming NNZ-2566 Phase 2 trial to be funded by US Army
• Total US Army funding represents approximately A$0.09 per share non-dilutive funding
• US FDA approves IND for NNZ-2566 Phase 2 trial
• US FDA grants “Fast Track” status

hi, how would that A$0.09 valuation be compared with yesterday's closing of A$0.024?? anyone would care to share? thanks in advance!

 

[johannlo]

Its not the same as having that amount in the bank as they have to spend it on that drug development and trial. They can't put it away for a rainy day, invest in something else, etc. so discount the valuation.

Previous to this announcement the cashflow situation was looking very dicey and everything was basically hinging on this announcement (which was anticipated, but we didn't know yay or nay or if yay how much $$$ etc.)

Still very much focused whether or not the drug succeeds. Indicators are that it will, or at least the US army thinks so, but who really knows.

After today's mad bull run I opted to take profits but I'm anticipating a retrace as most of today has been driven by traders. If it holds at 5c or above (no reason why not though I don't have any TA to back this up) then could be a good re-entry point. I don't buy into all the rampers who claim open at 7c and up to 11c tommorrow, the mad run is over and if its going to go to 11 it won't be overnight.

If you're not a gambler (and if you are should you really be in the stock market unless you're a gun trader?) and you missed out on the beginning then I would wait to see where this consolidates before punting. If the drug does make it then it will be worth a lot more than 11c anyway whereas if it falls in a heap and you chased the bull market you could be looking at a nasty loss. My hard earned experience as a newbie w/ biotechs I didn't know much about before punting.

Still a long way to go before the end game, proceed w/ caution (its a biotech, and an aussie one at that!!!).

 

[eMark]

Todays Announcement

10 July 2009
The Company Announcements Office
ASX Limited
Neuren Pharmaceuticals Limited
Share Purchase Plan
On 1 July 2009 Neuren Pharmaceuticals Limited (Neuren or the Company) announced that it would make another offer under its Share Purchase Plan (SPP) to shareholders. In compliance with ASX Listing Rules, Neuren provides the following information:
1. Neuren is offering each shareholder with a registered address in Australia or New Zealand a minimum of A$900 and a maximum of A$10,000 worth of new fully paid ordinary shares in the capital of the Company at a price of A$0.03 per share.
2. The SPP will be available to Australian and New Zealand shareholders who purchase shares on or before 13 July 2009 and are registered shareholders at 7.00pm (AEST) on 16 July 2009 (the Record Date).
3. The maximum number of shares which may be issued (without shareholder approval) is 77,239,293. Given the number of shareholders in Australia and New Zealand this SPP offer may be over-subscribed in which case the Company reserves the right to scale back acceptances or seek shareholder approval to issue a greater number of new fully paid ordinary shares.
4. Custodians acting as trustee or nominee in respect of more than one beneficiary will be able to apply for up to A$10,000 of new shares for each different beneficiary provided they give the certification and details of each beneficiary required by the Australian Securities and Investments Commission (ASIC) Class Order CO 09/425.
5. The new shares will on allotment rank equally with existing ordinary shares on issue.
6. The Company is able to make this offer to Australian shareholders without providing a disclosure document in accordance with class order relief provided by ASIC and the New Zealand Securities Act (Neuren Pharmaceuticals Limited) Exemption Notice 2009. A waiver has been sought from ASX regarding the recent increase in maximum subscription amount per annum by ASIC which exceeds the relevant Listing Rule exception. As noted above, should this SPP offer be over-subscribed the Company reserves the right to seek shareholder approval pursuant to ASX Listing Rule 7.1 for all or a part of the oversubscribed shares to be issued in the SPP.
7. The letter to shareholders setting out the terms of the SPP will be mailed to shareholders on 20 July 2009. Neuren Pharmaceuticals Limited
ARBN 111 496 130
8. The purposes of the SPP are to give shareholders the opportunity to subscribe for shares at a discounted share price of A$0.03 per share without having to incur brokerage fees, and to raise additional funds for the Company to meet working capital requirements.
Yours sincerely
Mr Rob Turnbull
Chief Financial Officer

 

[eMark]

Re - Todays announcement

Any comments from more experienced longer term holders of this stock?

It would be much appreciated

-------------------------------------------------------------------------

Ramblings from a newbie (Re NEU)

* From what I read this SPP was NOT UNEXPECTED.

* From what I have read, you can only purchase 10,000 dollars worth through the SPP. Not a lot really (333,333).

* The amount purchased has no relationship to the number of shares you already own?

* So if you really want to stock up, you have to buy on market anyway?

* It doesn't appear to hugely dilutionary?

* Also, in a way, why do they need to do a capital raing when they have recently been awarded 14m of funding from the army.

(I have been told that funds are now exhausted, reason for the new capital raising. Also the 14 m from the army was subsidising the exisiting expenses already spent on the trials so far).

* What's the likelihood of NEU pulling off a coup, and becoming successful? Obviously that question is from an investment point of view, not a traders point of view.

Just throwing it out there....

Also where does NEU stand in relationship to PRR Regarding potential success?

i.e. Which horse would you bet on?

Cheers

eMark

 

[pointr]

I regard our small holding in NEU now as more of a donation to a medical charity.
I didn't subscribe to the last SPP and nor will I to this one. My 'confidence' was particularly shaken by their trial of a compound to treat cognitive impairment following open heart surgery. It turns out from their study there wasn't significant impairment to begin with. It's acceptable not to find a cure for something, but couldn't they at least be sure there was a disease to start with.

 

[nesta3]

Over the last week NEU has been slowly creeping up, it could be because of the recent patent story that they are yet to announce which I am hoping that they will announce very soon for a quick few dollars...

Anybody else feel the same???

 

[desjosie]

http://www.neurenpharma.com/ssl/cms/files_cms/NEU%20Bell%20Potter%20Research%20Oct11.pdf

New Bell Potter report dated 18.10.2011
a 0.12c-0.21c sp predicted

good close today .023c ..up from .017c

 

[erichmj]

 

[michael_selway]

Anyone still hold these? It's gone up a bit these few days ^^ Thanks M.S

 

[pavilion103]

Yes. In at 3.5c last week.

I'm not a buy and hold guy though so will look to ride this move and exit.

 

[Country Lad]

New Bell Potter report dated 18.10.2011
a 0.12c-0.21c sp predicted

They still have it as a speculative buy - target 17c - as at their last bulletin 13 June. This one fooled me. I saw the break from 6 cents but thought it a bit risky. Then nothing much happened with the announcement of receiving 2 new patents so I didn't pay too much attention to it. 6 days later, away it went.

Cheers
Country Lad

 

[piggybank]

Still going north in a channel - of a sorts.....

 

[pixel]

Still going north in a channel - of a sorts.....

One year and some good news later, we're back there:

 

[peaksta]

Hi Guys, first time poster and newish (12 months) small time trader. I bought Neuren at .09 and have made approx 70% with my measly $1000. My question is - do you tend to sit on these small time medical companies all the way through when reports seem positive for the future, or am I just being greedy here.

Thanks

 

[pixel]

Hi Guys, first time poster and newish (12 months) small time trader. I bought Neuren at .09 and have made approx 70% with my measly $1000. My question is - do you tend to sit on these small time medical companies all the way through when reports seem positive for the future, or am I just being greedy here.

Thanks

Hello peaksta,
sorry I missed your Q at the time.
You may have noticed since that greed can be a two-edged sword, unless you know more about the company and its prospects. But even so, the correct answer to your question is "It depends."
... on whether you want to trade small positions for quick small profits,
... or whether you think you know the prospects and reap larger rewards over a longer timeframe,



I have been trading Neuren in medium-sized bites as the swings allowed. At the time of the Trading Halt, I was sitting on a small position (20k). I read and re-read the announcement and couldn't find any reason to suspect a complete wipe-out. Their drug is still effective, in the pipeline, and on track to be marketed.
Other people may see it differently - maybe they'll join this discussion with their ideas...

Today's breakout bodes well for next week; I get the feeling that another announcement - most likely better than the last - will be released shortly.

 

[peaksta]

Thanks Pixel, really appreciate you taking the time to reply. I have held on to them and was pleased to see they rebounded. Hope you are correct regarding upcoming news.

I guess with a drug it really is a wait and see and the negative response to, as you correctly stated, a monor setback, certainly showed me the voliatility here. I probably need to reasses goals as you stated above and work out if I know enough to believe I should see it through to the end date (doubtful, I am no scientist or doctor but could research) or just take some well earned profit when and if it happens

 

[pixel]

After a further slide, I think I see some signs of bottoming. In the absence of progress reports, I'm only taking small positions, but p&v suggests "someone might know something".